Israel Englander Renovo Rx, Inc. Transaction History

Millennium Management LLC

  • $175 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$0.9 - $1.43 $4,985 - $7,920
-5,539 Reduced 6.73%
76,814 $109,000
Q3 2024

Nov 14, 2024
SELL
$0.96 - $1.29 $3,804 - $5,112
-3,963 Reduced 4.59%
82,353 $87,000
Q2 2024

Aug 14, 2024
BUY
$1.02 - $1.46 $88,042 - $126,021
86,316 New
86,316 $97,000

Others Institutions Holding RNXT

# of Institutions
29
Shares Held
11M
Call Options Held
0
Put Options Held
0
View Full List

About RenovoRx, Inc.

RNXT Quotes by TradingView
  • Ticker RNXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,066,860
  • Market Cap $9.07M
  • Description
  • RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...
More about RNXT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email